Related Experiment Video
Updated: Aug 13, 2025
06:27
Use of a Monocyte Monolayer Assay to Evaluate Fcγ Receptor-mediated Phagocytosis
Published on: January 2, 2017
18.2K
Small Molecule Drugs That Inhibit Phagocytosis.
Melika Loriamini1,2, Melissa M Lewis-Bakker3, Kayluz Frias Boligan1
1Centre for Innovation, Canadian Blood Services, Toronto, ON M5G 2M1, Canada.
Molecules (Basel, Switzerland)
|January 21, 2023
Summary
Small molecules effectively inhibit phagocytosis, offering a new drug discovery approach for immune cytopenias like immune thrombocytopenic purpura. Two lead compounds show high efficacy and low toxicity in preclinical studies.
Area of Science:
- Immunology
- Pharmacology
- Drug Discovery
Background:
- Small molecules can inhibit phagocytosis, suggesting potential for treating immune cytopenias.
- Pyrazole core structures are effective and low-toxicity models for phagocytosis inhibitors.
Purpose of the Study:
- To explore a small molecule drug discovery approach for immune cytopenias.
- To identify and evaluate novel small molecule inhibitors of phagocytosis.
Main Methods:
- Screened a library of 80 compounds with pyrazole, isoxazole, and pyrrole cores.
- Evaluated compound toxicity using MTT viability, LDH release, and apoptosis assays.
- Assessed phagocytosis inhibition in vitro, determining IC50 values.
Main Results:
- Identified four hit compounds, all with a pyrazole core structure.
- Selected two lead compounds with negligible toxicity and high efficacy.
- Achieved in vitro IC50 values of 2-4 µM for phagocytosis inhibition.
Conclusions:
- Small molecule inhibitors targeting phagocytosis are feasible for immune cytopenia treatment.
- Two lead compounds demonstrate significant potential for further preclinical development.
- Further in vivo studies will guide the selection of a lead compound for clinical evaluation.
More Related Videos
Related Concept Videos
01:26Targets for Drug Action: Overview
6.9K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.9K
01:17Phagocytosis of Apoptotic Cells
3.9K
Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or immature dendritic cells. Non-professional phagocytes such as epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes.
Normal cells contain receptors that prevent them from being recognized...
Normal cells contain receptors that prevent them from being recognized...
3.9K
01:23Antimicrobial Proteins
2.7K
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
2.7K
00:41Phagocytosis
82.0K
Cells pull particles inward and engulf them in spherical vesicles in an energy-requiring process called endocytosis. Phagocytosis (“cellular eating”) is one of three major types of endocytosis. Cells use phagocytosis to take in large objects—such as other cells (or their debris), bacteria, and even viruses.
82.0K
01:28Biological Methods for Microbial Control
160
Biological agents offer an effective means of controlling microbial growth by leveraging natural processes like predation, competition, and the secretion of antimicrobial substances.Predatory bacteria such as Bdellovibrio species target and kill pathogens like Salmonella and E. coli. They are widely used in poultry farms to control infections. Myxococcus species help combat plant-pathogenic fungi. These naturally occurring predators serve as eco-friendly alternatives to chemical pesticides and...
160
01:24Principles of Drug Action
6.3K
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
6.3K